Clinuvel Pharmaceuticals Ltd (CUV) — Free Cash Flow Generation Index
Clinuvel Pharmaceuticals Ltd (CUV) has a Free Cash Flow Generation Index of 0.99x as of December 2025. Free cash flow of AU$12.38 Million represents 1% of operating cash flow (AU$12.52 Million). Explore CUV capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Clinuvel Pharmaceuticals Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Clinuvel Pharmaceuticals Ltd across 9 annual periods. For the full cash flow conversion analysis, see CUV cash flow metrics.
Annual Free Cash Flow Generation for Clinuvel Pharmaceuticals Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Clinuvel Pharmaceuticals Ltd. Check Clinuvel Pharmaceuticals Ltd (CUV) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | AU$40.80 Million | AU$41.10 Million | AU$298.57K | ▲ +16.9% |
| 2024 | 0.85x | AU$31.48 Million | AU$37.05 Million | AU$5.58 Million | ▼ -12.6% |
| 2023 | 0.97x | AU$35.88 Million | AU$36.91 Million | AU$1.03 Million | ▼ -1.7% |
| 2022 | 0.99x | AU$39.44 Million | AU$39.87 Million | AU$434.44K | ▲ +3.5% |
| 2021 | 0.96x | AU$18.41 Million | AU$19.26 Million | AU$854.33K | ▲ +2.0% |
| 2020 | 0.94x | AU$13.30 Million | AU$14.19 Million | AU$888.83K | ▼ -4.9% |
| 2019 | 0.99x | AU$18.20 Million | AU$18.46 Million | AU$257.62K | ▼ -0.8% |
| 2018 | 0.99x | AU$11.62 Million | AU$11.69 Million | AU$75.12K | ▲ +0.0% |
| 2017 | 0.99x | AU$9.85 Million | AU$9.92 Million | AU$67.48K | — |